The present study investigated the effect and mechanism of the novel HDAC6 inhibitor, MPT0G211 (N-hydroxy-4-((quinolin-8-ylamino)methyl)benzamide), on neuronal protection and cognitive function of AD models. This evidence concerns the gene HDAC6 and Alzheimer disease.